4.5 Article

Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction

期刊

EUROPEAN JOURNAL OF HEART FAILURE
卷 14, 期 8, 页码 902-908

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurjhf/hfs063

关键词

Tricuspid regurgitation; Functional mitral regurgitation; Prognosis; Heart failure

向作者/读者索取更多资源

The prognostic role of tricuspid regurgitation (TR) associated with organic left-sided valvular heart disease is well known. However, no data are available regarding the prognostic value of functional TR (FTR) in patients with functional mitral regurgitation (FMR) and left ventricular (LV) dysfunction. The purpose of this study was to evaluate the prognostic role of FTR for occurrence of heart failure (HF) and mortality in patients with FMR. We enrolled 373 consecutive patients (mean age 68 11 years) with LV dysfunction and at least mild FMR and with or without FTR, both quantitated by echocardiography. The median follow-up was 32 months (range 1120 months); 132 (35.4) and 97 patients developed HF or died, respectively. The incidence of HF at 3 and 6 years was 36 2 and 55 4, respectively. Moderate to severe FTR [hazard ratio (HR) 1.4, 95 confidence interval (CI) 1.12.1, P 0.01) was an independent determinant of HF. The incidence of HF was 41 5, 46 7, 57 7, and 65 8 for patients without, and with mild, moderate, and severe FTR respectively (P 0.03). At 3 and 6 years the survival free of all-cause mortality was 77.5 2 and 60 3, respectively. Moderate to severe FTR (HR 1.6, 95 CI 1.22.1, P 0.01) was an independent determinant of overall mortality. At 6 years, survival free of all-cause mortality was 69 2.5, 67 2.1, 51 2.5, and 40 4.8 for patients without, and with mild, moderate, and severe FTR, respectively (P 0.004). Moderate or more FTR is independently associated with worse survival and a high incidence of HF episodes in patients with FMR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据